SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-001929
Filing Date
2017-02-27
Accepted
2017-02-27 06:14:05
Documents
58
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1822300
2 ex23-1.htm EX-23.1 4225
3 ex31-1.htm EX-31.1 13350
4 ex31-2.htm EX-31.2 13335
5 ex32-1.htm EX-32.1 11360
6 figure_001.jpg GRAPHIC 40996
7 figure_002.jpg GRAPHIC 140335
8 figure_003.jpg GRAPHIC 75370
9 figure_004.jpg GRAPHIC 86975
10 figure_005.jpg GRAPHIC 64935
11 image_002.jpg GRAPHIC 36724
  Complete submission text file 0001493152-17-001929.txt   4577534

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE rttr-20161231.xml EX-101.INS 341352
13 XBRL SCHEMA FILE rttr-20161231.xsd EX-101.SCH 42237
14 XBRL CALCULATION FILE rttr-20161231_cal.xml EX-101.CAL 42144
15 XBRL DEFINITION FILE rttr-20161231_def.xml EX-101.DEF 114864
16 XBRL LABEL FILE rttr-20161231_lab.xml EX-101.LAB 285666
17 XBRL PRESENTATION FILE rttr-20161231_pre.xml EX-101.PRE 194796
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37428 | Film No.: 17639522
SIC: 2834 Pharmaceutical Preparations